Page last updated: 2024-08-24

imiquimod and Cancer Syndromes, Hereditary

imiquimod has been researched along with Cancer Syndromes, Hereditary in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, L; Huang, HZ; Li, W; Li, X; Lin, XX	1
Jia, J; Zhao, YF	1
Kouba, DJ; LoPiccolo, MC; Sage, RJ	1

Reviews

1 review(s) available for imiquimod and Cancer Syndromes, Hereditary

Article	Year
Biomarkers: important clues to the pathogenesis of infantile haemangioma and their clinical significance. The Chinese journal of dental research, 2010, Volume: 13, Issue:2 Topics: AC133 Antigen; Adjuvants, Immunologic; Aminoquinolines; Antigens, CD; Biomarkers; Calcium-Binding Proteins; DNA-Binding Proteins; Female; Glucose Transporter Type 1; Glycoproteins; Hemangioma, Capillary; Humans; Imiquimod; Infant; Microfilament Proteins; Neoplastic Syndromes, Hereditary; Neovascularization, Pathologic; Peptides; Placenta; Pregnancy; Receptors, Androgen; Skin Neoplasms	2010

Article

Year

Biomarkers: important clues to the pathogenesis of infantile haemangioma and their clinical significance.

The Chinese journal of dental research, 2010, Volume: 13, Issue:2

Topics: AC133 Antigen; Adjuvants, Immunologic; Aminoquinolines; Antigens, CD; Biomarkers; Calcium-Binding Proteins; DNA-Binding Proteins; Female; Glucose Transporter Type 1; Glycoproteins; Hemangioma, Capillary; Humans; Imiquimod; Infant; Microfilament Proteins; Neoplastic Syndromes, Hereditary; Neovascularization, Pathologic; Peptides; Placenta; Pregnancy; Receptors, Androgen; Skin Neoplasms

2010

Trials

1 trial(s) available for imiquimod and Cancer Syndromes, Hereditary

Article	Year
Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma. Dermatology (Basel, Switzerland), 2015, Volume: 230, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Extremities; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Imiquimod; Infant; Male; Neoplastic Syndromes, Hereditary; Non-Randomized Controlled Trials as Topic; Ointments; Ophthalmic Solutions; Skin Neoplasms; Timolol; Torso	2015

Article

Year

Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.

Dermatology (Basel, Switzerland), 2015, Volume: 230, Issue:2

Topics: Aminoquinolines; Antineoplastic Agents; Extremities; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Imiquimod; Infant; Male; Neoplastic Syndromes, Hereditary; Non-Randomized Controlled Trials as Topic; Ointments; Ophthalmic Solutions; Skin Neoplasms; Timolol; Torso

2015

Other Studies

1 other study(ies) available for imiquimod and Cancer Syndromes, Hereditary

Article	Year
Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:7 Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Carcinoma, Skin Appendage; Combined Modality Therapy; Humans; Imiquimod; Lasers, Solid-State; Male; Middle Aged; Neoplastic Syndromes, Hereditary; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2011

Article

Year

Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:7

Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Carcinoma, Skin Appendage; Combined Modality Therapy; Humans; Imiquimod; Lasers, Solid-State; Male; Middle Aged; Neoplastic Syndromes, Hereditary; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome

2011